Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.76), $0.20 better than the analyst estimate of ($0.96). Revenue for the quarter came in at $305.96 million versus the consensus estimate of $301.51 million.

For earnings history and earnings-related data on Insmed (INSM) click here.